Ashvin raises $16.5M to automate DME intake end to end

Ashvin has raised $16.5 million to expand its software for durable medical equipment providers, with new investment led by co-founder Mathew Mammen. The Boston startup says the funding will help add prior authorization and broaden its footprint after sixfold revenue growth since emerging from stealth last year.

Why it matters: - Durable medical equipment providers are under pressure from rising demand, lower reimbursement and staffing shortages. - Intake errors can lead to denied claims, delayed payments and audit findings weeks or months later. - Ashvin is betting that end-to-end automation can catch problems before an order ships, when fixes are cheaper.

What happened: - Ashvin announced a $16.5 million investment on October 12, 2026. - The round was led by co-founder Mathew Mammen, with participation from key industry leaders. - The company automates intake for durable medical equipment providers from referral arrival to qualified order. - Ashvin said the new capital will fund new capabilities, starting with prior authorization, and expand its reach across the DME market.

The details: - Ashvin reads referrals sent by fax or upload, verifies insurance and checks documentation against payer requirements. - The platform then sends qualified orders into a provider’s existing billing system. - Ashvin says the process typically takes about 10 minutes. - For some customers, 64% of orders are No-Touch Orders, meaning qualified orders delivered without any staff handling them. - When an order needs human review, Ashvin routes it to the provider’s team with the missing item and the reason flagged. - One customer passed a third-party administrator audit with no findings after using Ashvin. - Ashvin said it has grown revenue sixfold since emerging from stealth last year. - The company was founded in 2024 and is based in Boston. - Ashvin serves DME providers across the United States. - Bellevue Healthcare said Ashvin helped cut denial rates by 32% and freed staff from manual referral work. - Bellevue Healthcare serves patients across the Pacific Northwest. - Ashvin will be at the HME News Business Summit from October 12-14 in Louisville, Kentucky. - More information is available at Ashvin AI. - The company’s social profile is listed at Ashvin AI on LinkedIn.

Between the lines: - The raise suggests investors see workflow automation as a way to reduce costly downstream claim problems in a reimbursement-heavy industry. - Mammen’s background in DME sales gives the product pitch direct industry credibility. - The focus on prior authorization signals Ashvin is moving deeper into the most manual parts of DME revenue cycle work.

What's next: - Ashvin plans to roll out prior authorization features using the new funding. - The company also intends to expand further across the DME market. - Its presence at HME News Business Summit could help drive new customer and partner conversations. - Bellevue Healthcare is expected to continue sending more volume to Ashvin if performance holds.

The bottom line: - Ashvin is turning DME intake into a software-driven workflow, and the new funding gives the company room to widen that automation beyond referral handling.